Literature DB >> 25674296

Effects of icariin on cytokine-induced ankylosing spondylitis with fibroblastic osteogenesis and its molecular mechanism.

Chunrong Jia1, Hongxiao Liu2, Min Li3, Zhikui Wu3, Xinghua Feng2.   

Abstract

The aim of this study is to explore the effects of icariin on cytokine induced ankylosing spondylitis fibroblast osteogenesis type expression and its molecular mechanism. The normal fibroblasts were collected as normal control group, and the fibroblasts of hip joint capsule of AS patients were collected, which were respectively added in fetal bovine serum (group AS), fetal bovine serum and cytokines (BMP-2+TGF-beta 1) (group AS), and cell factor solution (icariin group), and observed of the osteogenic expression of fibroblast, to evaluate the impact of Icariin on it. The ALP activity, the content of collagen, osteocalcin content and cbfa1mRNA and OCmRNA of fibroblast of AS group increased compared to the normal control group and AS control group (P < 0.01), indicating that icariin can significantly inhibit the above changes (P < 0.01). Icariin can inhibit fibroblast further osteogenic differentiation through inhibiting the effect of cytokines on the fibroblast osteogenesis type markers and osteogenic gene expression and osteogenic differentiation.

Entities:  

Keywords:  Ankylosing spondylitis; cytokine; fibroblast; icariin; ossification

Mesh:

Substances:

Year:  2014        PMID: 25674296      PMCID: PMC4314045     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  21 in total

Review 1.  Global prevalence of ankylosing spondylitis.

Authors:  Linda E Dean; Gareth T Jones; Alan G MacDonald; Christina Downham; Roger D Sturrock; Gary J Macfarlane
Journal:  Rheumatology (Oxford)       Date:  2013-12-09       Impact factor: 7.580

Review 2.  Regulation of bone formation by bone morphogenetic proteins and other growth factors.

Authors:  G R Mundy
Journal:  Clin Orthop Relat Res       Date:  1996-03       Impact factor: 4.176

Review 3.  Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials.

Authors:  Amanda J Steiman; Janet E Pope; Heather Thiessen-Philbrook; Lihua Li; Cheryl Barnabe; Fares Kalache; Tabitha Kung; Louis Bessette; Cathy Flanagan; Boulos Haraoui; Jacqueline Hochman; Sharon Leclercq; Dianne Mosher; Carter Thorne; Vivian Bykerk
Journal:  Rheumatol Int       Date:  2013-01-06       Impact factor: 2.631

4.  Temporal and spatial patterns of cbfal expression during embryonic development in the teleost, Oryzias latipes.

Authors:  K Inohaya; A Kudo
Journal:  Dev Genes Evol       Date:  2000-11       Impact factor: 0.900

5.  Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover.

Authors:  Gianni M Di Guglielmo; Christine Le Roy; Anne F Goodfellow; Jeffrey L Wrana
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

6.  SDF-1α/CXCR4 signaling mediates digit tip regeneration promoted by BMP-2.

Authors:  Jangwoo Lee; Luis Marrero; Ling Yu; Lindsay A Dawson; Ken Muneoka; Manjong Han
Journal:  Dev Biol       Date:  2013-08-02       Impact factor: 3.582

7.  Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts.

Authors:  S E Harris; L F Bonewald; M A Harris; M Sabatini; S Dallas; J Q Feng; N Ghosh-Choudhury; J Wozney; G R Mundy
Journal:  J Bone Miner Res       Date:  1994-06       Impact factor: 6.741

Review 8.  Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.

Authors:  Noemi Busquets-Perez; Helena Marzo-Ortega; Paul Emery
Journal:  Expert Opin Emerg Drugs       Date:  2012-12-20       Impact factor: 4.191

9.  Ankylosing spondylitis: from cells to genes.

Authors:  José Francisco Zambrano-Zaragoza; Juan Manuel Agraz-Cibrian; Christian González-Reyes; Ma de Jesús Durán-Avelar; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2013-07-21

10.  Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study.

Authors:  Dinny Wallis; Arundip Asaduzzaman; Michael Weisman; Nigil Haroon; Ammepa Anton; Dermot McGovern; Stephan Targan; Robert Inman
Journal:  Arthritis Res Ther       Date:  2013-10-26       Impact factor: 5.156

View more
  3 in total

Review 1.  The Role of MicroRNAS in Ankylosing Spondylitis.

Authors:  Zheng Li; Sunny H Wong; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

2.  A retrospective study of transcutaneous electrical nerve stimulation for chronic pain following ankylosing spondylitis.

Authors:  Fu-Chun Chen; Zhen-Ling Jin; Deng-Feng Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

3.  microRNA-214-3p Suppresses Ankylosing Spondylitis Fibroblast Osteogenesis via BMP-TGFβ Axis and BMP2.

Authors:  Lixiang Ding; Yukun Yin; Yu Hou; Haoran Jiang; Ji Zhang; Zhong Dai; Genai Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-15       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.